Document is current
Any future updates will be listed below
-
Authors
Pabon, Elisa
Cooper, Ziva D. https://orcid.org/0000-0001-8001-2332
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R25DA050723, DA047296)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Semel Charitable Foundation
- License Information
-
More Information
Article History
Received: 23 December 2022
Revised: 13 January 2023
Accepted: 18 January 2023
First Online: 1 February 2023
Competing interests
: The authors declare that they have no competing interests or disclosures with this publication. Outside of this work, ZDC reports receiving study drug from Canopy Growth Corp and True Terpenes, and study-related materials from Storz & Bickel. She served a scientific consultant for Canopy Growth Corporation in 2021 and on the scientific advisory board for FSD Pharma in 2020. ZDC’s research is funded by grants from the National Institute on Drug Abuse, National Center for Complementary and Integrative Health, California Department of Cannabis Control, Center for Medicinal Cannabis Research, and the California Highway Patrol.
